Infectious Disease Diagnostics Market by Product Type (Consumables, Instruments, and Software & Services), By Test Type (Laboratory test, Imaging test, and Biopsies), and by Application (Bacterial Infection, Viral Infection, CNS infections, Cardiovascular infection, Fungal infection, GI infections, Sexually transmitted disease, and Other Applications), by End-users (Diagnostic laboratories, Academic and Medical institutes, Contract Research Organization, Hospitals and Surgical centers, Ambulatory clinics, and Home healthcare)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the infectious disease diagnostics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the infectious disease diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the infectious disease diagnostics market on a global level.

In order to give the users of this report a comprehensive view on the infectious disease diagnostics market, we have included competitive landscape and analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where product type, test type, applications, end–user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view of the infectious disease diagnostics market by segmenting the market based on product type, test type, applications, end-user, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024.

Based on product type, the infectious disease diagnostics market is segmented as consumables, instruments, and software & services. Based on the test type, the infectious disease diagnostics market is segmented into laboratory tests, an imaging test, and biopsies. Based on application, the infectious disease diagnostics market is segmented into bacterial infection, viral infection, CNS Infections, cardiovascular infection, fungal infection, GI infections, sexually transmitted disease and other Based on end-user, the infectious disease diagnostics market is segmented as diagnostic laboratories, academic and medical institutes, contract research organization, hospitals, and surgical centers, ambulatory clinics, and home healthcare.

Increased prevalence of infectious diseases is one of the major driving factors of infectious disease diagnostics market. Increase in research and development coupled with the development of novel technologies are expected to drive the growth of Infectious disease diagnostics market. However, lack of awareness about advanced technologies and poor laboratory conditions are the factors that influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries, including the U.S., Germany, France, the UK, China, Japan, India, and Brazil. This segment includes the demand for infectious disease diagnostics market based on individual segment and treatment in all the regions and countries.

The report also includes detailed profiles of end-players such as Becton Dickinson & Company, Affymetrix, Abbott Laboratories, Cepheid Inc., BioMerieux, Hologic Inc., DiaSorin, Bio-Rad Laboratories Inc., Alere Inc., and Danaher Corporation and others.

This report segments the global infectious disease diagnostics market as follows:

Global Infectious Disease Diagnostics Market: Product Type Segment Analysis

	Consumables
	Instruments
	Software & Services

Global Infectious Disease Diagnostics Market: Test Type Segment Analysis

	Laboratory Tests
	Imaging Test
	Biopsies

Global Infectious Disease Diagnostics Market: Applications Segment Analysis

	Bacterial Infection
	Viral Infection
	CNS Infections
	Cardiovascular Infection
	Fungal Infection
	GI Infections
	Sexually Transmitted Disease
	Other

Global Infectious Disease Diagnostics Market: End-User Segment Analysis

	Diagnostic Laboratories,
	Academic and Medical Institutes
	Contract Research Organization
	Hospitals and Surgical Centers
	Ambulatory Clinics


	Home Healthcare

Global Infectious Disease Diagnostics Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa